Category: Pharma Industry

Arkansas Looks to Amend Temporary Contract Pharmacy Agreement with Novo Nordisk

January 25, 2024 Rich Daly, Editor in Chief Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

After hospitals in Arkansas raised concerns over details of an agreement by Novo Nordisk to temporarily loosen contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arizona State Senators Introduce Latest 340B Contract Pharmacy Bill

January 25, 2024 William Newton, Associate Editor/Senior Writer Views

Two influential Arizona state senators recently introduced a bill that would prohibit drugmaker restrictions on 340B contract pharmacy use.

Two high-ranking Republican Arizona state senators have introduced a bill that would bar drug manufacturer restrictions on 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provider-Drugmaker Lobbying Group Adds Two More Manufacturers

January 23, 2024 Rich Daly, Editor in Chief Views

340B Working Table's lobbying disclosure filing.

A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’

January 23, 2024 Rich Daly, Editor in Chief Views

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.

A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

January 23, 2024 William Newton, Associate Editor/Senior Writer Views

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.

A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Iowa 340B Contract Pharmacy Bill Introduced; Companion Bills Debut in West Virginia, Oklahoma

January 23, 2024 William Newton, Associate Editor/Senior Writer Views

Iowa is the latest state to introduce a bill to shield 340B contract pharmacy arrangements from manufacturer restrictions.

A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie Pushes to Block Louisiana 340B Contract Law, New State AG Takes Office

January 19, 2024 William Newton, Associate Editor/Senior Writer Views

In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.

Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two More States Introduce 340B Contract Pharmacy Protection Bills

January 17, 2024 William Newton, Associate Editor/Senior Writer Views

Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Makers Issue Record Number of 340B Refunds in 2023, Merck First to Refund in 2024

January 17, 2024 Rich Daly, Editor in Chief Views

Drugmakers issued a record 41 refunds to 340B covered entities in 2023.

Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Takeda to Expand 340B Contract Pharmacy Restrictions

January 17, 2024 Rich Daly, Editor in Chief Views

Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.

Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live